Formulation of Pharmaceutical Tablets Containing <i>β</i>-Cyclodextrin-4-Methyl-Umbelliferone (Hymecromone) Inclusion Complexes and Study of the Dissolution Kinetics

Formulation of Pharmaceutical Tablets Containing <i>β</i>-Cyclodextrin-4-Methyl-Umbelliferone (Hymecromone) Inclusion Complexes and Study of the Dissolution Kinetics

The present study focuses on the synthesis of the natural product 4-methyl-umbelliferone (4-MU, hymecromone), the preparation, characterization, and biological activity evaluation of 4-MU inclusion complexes with <i>β</i>-cyclodextrin (<i>β</i>-CD), as well as their incorpora...

Full description

Bibliographic Details
Main Authors: Eleni Kavetsou, Ioanna Pitterou, Nikos G. Dimitrioglou, Stefanos Kikionis, Eftichia Kritsi, Panagiotis Zoumpoulakis, Eleni Pontiki, Dimitra Hadjipavlou-Litina, Dimitris T. Hatziavramidis, Anastasia Detsi
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Micro
Subjects:
4-methyl-umbelliferone
<i>β</i>-cyclodextrin
excipients
formulation
pharmaceutical tablets
release profile
Online Access:https://www.mdpi.com/2673-8023/3/4/61

Internet

https://www.mdpi.com/2673-8023/3/4/61

Similar Items